Saturday, November 2, 2024
HomeTagsEuropean Commission

European Commission

European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis

Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for VELSIPITY (etrasimod) in the European Union to treat patients 16 years...

Dupixent Approved by European Commission as the First and Only Targeted Medicine

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) in the European Union to...

Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group ("Menarini"), a privately-held, leading international pharmaceutical company, announced that...

Brand Institute Partners on Brand Name Development for European Commission Approved Treatment

Brand Institute is proud to announce having worked with Myovant Sciences in developing the brand name ORGOVYX, for an oral medication used to treat...

European Commission Selects Dow’s Accutrace™ Plus Fuel Marker as the New EU Common Fiscal Marker to Support Fuel Fraud Prevention

The European Commission selected Dow ACCUTRACE Plus Fuel Marker as the new common fiscal marker for tax rebated fuels in the European Union (EU)....
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics